Εσθονία - Εσθονικά - Ravimiamet

fgup npo microgen mz rf - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

Εσθονία - Εσθονικά - Ravimiamet

fgup “armaviri biofabrika” - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

Εσθονία - Εσθονικά - Ravimiamet

serumwerk bernburg ag - kaltsiumkloriid - infusioonilahus - 73,5mg 1ml 100ml 20tk

Εσθονία - Εσθονικά - Ravimiamet

b. braun melsungen ag - naatriumkloriid - süstelahus - 200mg 1ml 20ml 20tk

Εσθονία - Εσθονικά - Ravimiamet

dalhimfarm oao - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

Εσθονία - Εσθονικά - Ravimiamet

galychpharm - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

Εσθονία - Εσθονικά - Ravimiamet

apex formulations pvt. ltd. - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 100tk

Εσθονία - Εσθονικά - Ravimiamet

darnitsa pharmaceutical firm prat - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.